• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺激动剂的历史与药理学

The history and pharmacology of dopamine agonists.

作者信息

Lataste X

出版信息

Can J Neurol Sci. 1984 Feb;11(1 Suppl):118-23. doi: 10.1017/s0317167100046266.

DOI:10.1017/s0317167100046266
PMID:6713309
Abstract

The recognition of the dopaminergic properties of some ergot derivatives has initiated new therapeutical approaches in endocrinology as well as in neurology. The pharmacological characterization of the different ergot derivatives during the last decade has largely improved our understanding of central dopaminergic systems. Their development has yielded valuable information on the pharmacology of dopamine receptors involved in the regulatory mechanisms of prolactin secretion and in striatal functions. The clinical application of such new neurobiological concepts has underlined the therapeutical interest of such compounds either in the control of prolactin-dependent endocrine disorders or in the treatment of parkinsonism. Owing to their pharmacological profiles, dopaminergic agonists represent a valuable clinical option especially in the management of Parkinson's disease in view of the problems arising from chronic L-Dopa treatment.

摘要

某些麦角衍生物的多巴胺能特性的发现,在内分泌学和神经学领域开创了新的治疗方法。在过去十年中,对不同麦角衍生物的药理学特性进行了深入研究,这极大地增进了我们对中枢多巴胺能系统的理解。它们的研发为参与催乳素分泌调节机制和纹状体功能的多巴胺受体药理学提供了有价值的信息。这些新的神经生物学概念的临床应用凸显了此类化合物在控制催乳素依赖性内分泌疾病或治疗帕金森病方面的治疗价值。鉴于长期使用左旋多巴治疗引发的问题,多巴胺能激动剂因其药理学特性,成为一种有价值的临床选择,尤其在帕金森病的治疗中。

相似文献

1
The history and pharmacology of dopamine agonists.多巴胺激动剂的历史与药理学
Can J Neurol Sci. 1984 Feb;11(1 Suppl):118-23. doi: 10.1017/s0317167100046266.
2
Dopamine agonists in Parkinson's disease.帕金森病中的多巴胺激动剂
Can J Neurol Sci. 1984 Feb;11(1 Suppl):221-4. doi: 10.1017/s0317167100046448.
3
DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S68-71. doi: 10.1002/mds.5563.
4
DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.多巴胺激动剂——麦角衍生物:二氢麦角隐亭(DHEC):帕金森病的治疗
Mov Disord. 2002;17 Suppl 4:S72-3. doi: 10.1002/mds.5564.
5
DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.多巴胺激动剂——麦角衍生物:培高利特:帕金森病的治疗
Mov Disord. 2002;17 Suppl 4:S79-82. doi: 10.1002/mds.5566.
6
DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.多巴胺激动剂——麦角衍生物:利苏瑞得:帕金森病的治疗
Mov Disord. 2002;17 Suppl 4:S74-8. doi: 10.1002/mds.5565.
7
Pharmacology of ergot alkaloids in clinical use.临床应用中麦角生物碱的药理学。
Med J Aust. 1978 Nov 4;2(3 Suppl):3-13. doi: 10.5694/j.1326-5377.1978.tb77379.x.
8
[Pharmacological basis for the therapeutic use of ergot alkaloids].[麦角生物碱治疗应用的药理学基础]
Presse Med. 1983 Feb 19;12(8):517-20.
9
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.多巴胺激动剂——麦角衍生物:溴隐亭:帕金森病的治疗
Mov Disord. 2002;17 Suppl 4:S53-67. doi: 10.1002/mds.5562.
10
[Dopaminergic ergot combinations. A new therapeutic principle].[多巴胺能麦角碱组合。一种新的治疗原则]
MMW Munch Med Wochenschr. 1983 Jun 10;125(23):489-91.

引用本文的文献

1
Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's disease.采用拉姆斯菲尔德的方法来理解左旋多巴和阿朴吗啡在帕金森病中的作用。
J Neural Transm (Vienna). 2023 Nov;130(11):1337-1347. doi: 10.1007/s00702-023-02655-0. Epub 2023 May 20.